Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Systemic Scleroderma
85%
Rituximab
71%
Interstitial Lung Disease
71%
Combination Therapy
28%
Patient
28%
Serum
14%
Diseases
14%
Disease Activity
14%
B Cell
14%
Antibody
14%
Autoimmune Disease
14%
Topoisomerase
14%
CD20 Antibody
14%
Drug
14%
Chemotherapeutic Agent
14%
Therapeutic Procedure
14%
Experience
14%
Medication
14%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Systemic Sclerosis
85%
Interstitial Lung Disease
71%
Rituximab
71%
Diseases
14%
Antibody
14%
Autoimmune Disease
14%
Drug
14%
Disease Activity
14%
DNA Topoisomerase
14%
Sclerosis
14%
CD20 Antibody
14%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Systemic Scleroderma
85%
Rituximab
71%
Lung
71%
B Cell
14%
Autoimmune Disease
14%
Monospecific Antibody
14%
CD20 Antibody
14%
Time
14%
Reduction (Chemistry)
14%
Experience
14%